124 related articles for article (PubMed ID: 958534)
21. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
[TBL] [Abstract][Full Text] [Related]
22. Transplantable metastasizing prostate adenocarcinomas in rats.
Pollard M; Luckert PH
J Natl Cancer Inst; 1975 Mar; 54(3):643-9. PubMed ID: 1123852
[TBL] [Abstract][Full Text] [Related]
23. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
[TBL] [Abstract][Full Text] [Related]
24. [The aggressiveness of prostatic cancer in relation to classification and grading].
Mehlhorn J
Z Urol Nephrol; 1988 Apr; 81(4):203-11. PubMed ID: 3400348
[TBL] [Abstract][Full Text] [Related]
25. Human prostate cancer progression models and therapeutic intervention.
Chung LW; Kao C; Sikes RA; Zhau HE
Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
[TBL] [Abstract][Full Text] [Related]
26. [Bone metastasis of prostate cancer: an update].
Tang H; Zhang ZY
Zhonghua Nan Ke Xue; 2010 Apr; 16(4):364-7. PubMed ID: 20626169
[TBL] [Abstract][Full Text] [Related]
27. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature.
Shen ML; Kang J; Wen YL; Ying WM; Yi J; Hua CG; Tang XF; Wen YM
J Oral Maxillofac Surg; 2009 Apr; 67(4):718-37. PubMed ID: 19304027
[TBL] [Abstract][Full Text] [Related]
28. [Metastases of prostatic cancer].
Samsonov VA
Arkh Patol; 1985; 47(8):58-61. PubMed ID: 4074149
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
[TBL] [Abstract][Full Text] [Related]
31. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM
Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685
[TBL] [Abstract][Full Text] [Related]
32. [Endoscopic endobronchial metastasis].
Tsukamoto T; Nagasawa M; Yamada K; Satoh T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Apr; 30(4):609-13. PubMed ID: 1405076
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
[TBL] [Abstract][Full Text] [Related]
34. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
[TBL] [Abstract][Full Text] [Related]
36. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
[TBL] [Abstract][Full Text] [Related]
37. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker.
Rubio N; Villacampa MM; Blanco J
Lab Invest; 1998 Oct; 78(10):1315-25. PubMed ID: 9800957
[TBL] [Abstract][Full Text] [Related]
38. [Distribution of lung cancer metastases. I. Combination and frequency of organ metastases].
Barz H; Barz D; Klemm P
Arch Geschwulstforsch; 1982; 52(7):551-60. PubMed ID: 7165490
[TBL] [Abstract][Full Text] [Related]
39. Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression.
Yang M; Hasegawa S; Jiang P; Wang X; Tan Y; Chishima T; Shimada H; Moossa AR; Hoffman RM
Cancer Res; 1998 Oct; 58(19):4217-21. PubMed ID: 9766640
[TBL] [Abstract][Full Text] [Related]
40. Lymphatogenous spread of renal cell carcinoma: an autopsy study.
Johnsen JA; Hellsten S
J Urol; 1997 Feb; 157(2):450-3. PubMed ID: 8996329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
